Verified· 2 sources

DeepVax GmbH

Summary

About the company

The core activity of DeepVax GmbH is the development, manufacture and marketing of innovative therapeutic vaccines against chronic inflammatory diseases, obesity, aging and cancer.

AI-generated

Offering

Products & services

Industry:Pharmaceutical Industry

✓ Offered7

Therapeutic vaccines

Therapeutic vaccines based on optimised Virus-like Particles (VLPs) for active immunisation against chronic diseases and disease-causing endogenous molecules.

Vaccines against inflammation

Vaccines against chronic inflammation in skin, lungs and heart, developed based on clinically validated target structures and molecular modelling.

Vaccines against obesity

Vaccines to support novel therapies against obesity, developed with molecular modelling for more affordable use.

Vaccines against aging and Alzheimer

Vaccines against age-associated inflammatory processes and Alzheimer’s disease, with preclinically tested candidates for neurodegeneration.

Personalised cancer vaccines

Personalised cancer vaccines based on VLPs, developed using immunopeptidomics and Whole-Exome-Sequencing to identify patient-specific tumour antigens.

Outbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub

DeepVax GmbH

About the company

Products & services

Looking for direct email addresses and phone numbers?

DeepVax GmbH

About the company

Products & services

Looking for direct email addresses and phone numbers?

No knowledge articles yet

DeepVax GmbH in comparison

Industry comparisons are coming soon

Similar companies